Survivin is highly expressed on pancreatic tumour cells and allows them to avoid apoptosis, making it a credible target for immunotherapy treatments aiming to activate lymphocytes and kill tumour cells with high survivin expression [23,109]. The gene discussed is BIRC5; the disease is neoplasm.